Kardiyorenal Sendrom

Curran J. The Yellow Emperor’s Classic of Internal Medicine. BMJ. 2008 Apr 5;336(7647):777.
Ghalioungui P. The Ebers papyrus: a new English translation, commentaries and glossaries. Cairo: Academy of Scientific Research and Technology; 1987
Diamandopoulos A. Twelve centuries of nephrological writings in the Graeco-Roman world of the Eastern Mediterranean (from Hippocrates to Aetius Amidanus). Nephrol Dial Transplant. 1999;14.
Keele KD. The concept of heart failure from Avicenna to Albertini. Med Hist. 1981 Oct;25(4):434–5. PMCID: PMC1139078.
Timio M. Gentile da Foligno, a pioneer of cardionephrology: commentary on Carmina de urinarum iudiciis and De pulsibus. Am J Nephrol. 1999;19(2):189-92.
Bright R. Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine. Guy’s Hosp Rep. 1836;1:338-400.
Kikes WS. On apoplexy in relation to chronic renal disease. Med Times Gaz.1885;24:515-517.
Traube L. Ueber den Zusammenhang von Herz-und Nierenkrank-heaten gesammelte beitrage zur pathologie und physiologie. Berlin: Nirschwald;1871. p. 290-353.
Lewis T. A Clinical Lecture ON PAROXYSMAL DYSPNOEA IN CARDIORENAL PATIENTS: WITH SPECIAL REFERENCE TO "CARDIAC" AND "URAEMIC" ASTHMA: Delivered at University College Hospital, London, November 12th, 1913. Br Med J. 1913 Nov 29;2(2761):1417-20.
Heywood JT. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev. 2004 Jul;9(3):195-201. doi: 10.1007/s10741-005-6129-4. PMID: 15809817.
Ronco C, McCullough P, Anker SD at al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010 Mar;31(6):703-11.
Zannad F, Rossignol P. Cardiorenal Syndrome Revisited. Circulation. 2018 Aug 28;138(9):929-944.
Heywood JT, Fonarow GC, Costanzo MR et al.ADHERE Scientific Advisory Committee and Investigators. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007 Aug;13(6):422-30.
Mavrakanas TA, Khattak A, Singh K et al. Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1624-1633.
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007 Aug;154(2):260-6.
Damman K, Navis G, Voors AA, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007 Oct;13(8):599-608.
Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol. 1989 Feb 15;63(7):461-4.
W.H. Wilson Tang, Frederik H. Verbrugge, Wilfried Mullens(2020). Cardiorenal syndrome in heart failure (first edition). Sipringer publishing group. 2020.
Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019 Nov 23;394(10212):1949-1964.
Ronco C, Haapio M, House AA at al. Cardiorenal syndrome. J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39.
Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989 Feb 10;261(6):884-8. PMID: 2913385.
Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006 Jul;34(7):1913-7.
Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008 Apr;23(4):1203-10.
Gursu M, Yegenaga I, Tuglular S et al. Acute kidney injury in Turkey: epidemiological characteristics, etiology, clinical course, and prognosis. BMC Nephrol. 2022 Oct 5;23(1):326.
Alan S. L. Yu, Glenn M. Chertow, Philip A. Marsden, Valerie Luyckx, Maarten W. Taal, Karl Skorecki (2019). Brenner & Rector's The Kidney (11. Edition). Elsevier, Year: 2019
Hillege HL, Nitsch D, Pfeffer MA et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006 Feb 7;113(5):671-8.
Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006 Jul 20;355(3):260-9.
Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008 Apr 1;51(13):1268-74.
Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008 Jan;36(1 Suppl):S75-88.
Fu P, Arcasoy MO. Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis. Biochem Biophys Res Commun. 2007 Mar 9;354(2):372-8.
Riksen NP, Hausenloy DJ, Yellon DM. Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci 2008;29: 258–67
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7-11.
Süleymanlar G, Utaş C, Arinsoy T, at al. A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant. 2011 Jun;26(6):1862-71.
Rangaswami J, Bhalla V, Blair JEA, et al. American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 Apr 16;139(16):e840-e878.
van Duijnhoven EC, Cheriex EC, Tordoir JH, et al. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant. 2001 Feb;16(2):368-72.
Vallabhajosyula S, Sakhuja A, Geske JB, et al. Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study. PLoS One. 2018 Jan 9;13(1):e0190965.
Cardiorenal Syndrome Guidelines Working Group of Chinese Nephrologist Association of Chinese Medical Doctor Association. [Clinical practice guideline for the diagnosis and treatment of cardiorenal syndrome (2023 Edition)]. Zhonghua Yi Xue Za Zhi. 2023 Dec 12;103(46):3705-3759.
Schanz M, Shi J, Wasser C, et al. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure. Clin Cardiol. 2017 Jul;40(7):485-491.
Palazzuoli A, Ruocco G, Pellegrini M, et al. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure. Am J Cardiol. 2015 Jul 1;116(1):104-11.
Murty MS, Sharma UK, Pandey VB, et al. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 2013 May;23(3):180-3. doi: 10.4103/0971-4065.111840. PMID: 23814415; PMCID: PMC3692142.
Matsushita K, Coresh J, Sang Y, et al. CKD Prognosis Consortium. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25.
Matsushita K, Kwak L, Sang Y, et al. Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2017 Sep 22;6(9):e006259.
Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011 Nov;121(11):4393-408.
Scialla JJ, Xie H, Rahman M, et al. Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2014 Feb;25(2):349-60.
Ricci Z, Romagnoli S, Ronco C. Cardiorenal Syndrome. Crit Care Clin. 2021 Apr;37(2):335-347.
Badger S, McVeigh J, Indraratna P. Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines. Cardiol Ther. 2023 Dec;12(4):571-588.
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of theAcuteDialysisQualityInitiative (ADQI) Group. CritCare 2004; 8:B204.
Mehta RL, Kellum JA, Shah SV, et al. AcuteKidneyInjury Network: report of an initiative toimprove outcomes in acute kidney injury. CritCare 2007; 11:R31.
KidneyDisease: Improving Global Outcomes (KDIGO). Acute Kidney Injury Work Group. KDIGO clinical practice guidelines for acute kidney injury. KidneyIntSuppl 2012; 2:1.
Gheorghiade M, Follath F, Ponikowski P, et al. European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May;12(5):423-33.
Yancy CW, Jessup M, Bozkurt B, at al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017 Aug;23(8):628-651.
Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129-2200.
van Kimmenade RR, Pinto YM, Januzzi JL Jr. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations. Am J Cardiol. 2008 Feb 4;101(3A):39-42.
Racek J, Králová H, Trefil L, Rajdl D, Eiselt J. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract. 2006;103(4):c162-72.
Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrol Dial Transplant. 2009 Jun;24(6):1962-9.
Twerenbold R, Wildi K, Jaeger C, et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015 Jun 9;131(23):2041-50.
Kellum, J. A., Romagnani, P., Ashuntantang, G., Ronco, C., Zarbock, A., & Anders, H. (2021). Acute kidney injury. Nature Reviews Disease Primers, 7(1), 1-17.
Pasala S, Carmody JB. How to use… serum creatinine, cystatin C and GFR. Arch Dis Child Educ Pract Ed. 2017 Feb;102(1):37-43.
Cummings JJ, Shaw AD, Shi J, Lopez MG, O'Neal JB, Billings FT 4th. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J Thorac Cardiovasc Surg. 2019 Apr;157(4):1545-1553.e5.
McIlroy DR, Wagener G, Lee HT. Biomarkers of acute kidney injury: an evolving domain. Anesthesiology. 2010 Apr;112(4):998-1004.
Argaiz ER, Romero-Gonzalez G, Rola P, et al. Bedside Ultrasound in the Management of Cardiorenal Syndromes: An Updated Review. Cardiorenal Med. 2023;13(1):372-384.
Zhao X, Ren Y, Li H,et al. The Effect of Diuretics on Patients with Heart Failure: A Network Meta-Analysis: Diuretics Effect on Heart Failure Patients. J Pharm Pharm Sci. 2019;22(1):270-280.
Bove T, Belletti A, Putzu A, et al. Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials. PLoS One. 2018 Apr 24;13(4):e0196088.
Chan JSK, Kot TKM, et al. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis. J Card Fail. 2020 Sep;26(9):786-793.
Verbrugge FH, Martens P, Ameloot K, et al. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019 Nov;21(11):1415-1422.
Núñez J, Llàcer P, García-Blas S, et al. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction. Am J Med. 2020 Mar;133(3):370-380.e4.
Luo X, Jin Q, Wu Y. Tolvaptan add-on therapy in patients with acute heart failure: A systematic review and meta-analysis. Pharmacol Res Perspect. 2020 Jun;8(3):e00614.
Patarroyo M, Wehbe E, Hanna M, et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol. 2012 Nov 6;60(19):1906-12.
Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015 Mar;12(3):184-92.
Gupta R, Testani J, Collins S. Diuretic Resistance in Heart Failure. Curr Heart Fail Rep. 2019 Apr;16(2):57-66.
Luk A, Groarke JD, Desai AS, et al. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. Am Heart J. 2018 Sep;203:95-100.
Premuzic V, Basic-Jukic N, et al. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration. Ther Apher Dial. 2017 Jun;21(3):279-286.
Al-Hwiesh AK, Abdul-Rahman IS, et al. Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study. Int J Artif Organs. 2019 Dec;42(12):684-694.
McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):523.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 May 3;79(17):1757-1780.
Gong B, Li Z, Yat Wong PC. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1415-25.
Gong B, Li Z, Yat Wong PC. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1415-25.
Tang X, Liu P, Li R, et al. Milrinone for the Treatment of Acute Heart Failure After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. Basic Clin Pharmacol Toxicol. 2015 Sep;117(3):186-94.
Gencer E, Doğan V, Öztürk MT, et al. Comparison of the Effects of Levosimendan Dobutamine and Vasodilator Therapy on Ongoing Myocardial Injury in Acute Decompensated Heart Failure. J Cardiovasc Pharmacol Ther. 2017 Mar;22(2):153-158.
Testani JM, Brisco MA, Tang WH, et al. Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure. J Card Fail. 2013 May;19(5):295-302.
Liu Y, Sun JY, Zhu YS, et al. Association between CRT(D)/ICD and renal insufficiency: A systematic review and meta-analysis. Semin Dial. 2021 Jan;34(1):17-30.
McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007 Jun 13;297(22):2502-14.
Boerrigter G, Costello-Boerrigter LC, Abraham WT, et al. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail. 2008 Sep;14(7):539-46.
Obradovic D, Freund A, Feistritzer HJ, et al. Temporary mechanical circulatory support in cardiogenic shock. Prog Cardiovasc Dis. 2021 Nov-Dec;69:35-46.
Atti V, Narayanan MA, Patel B, et al. A Comprehensive Review of Mechanical Circulatory Support Devices. Heart Int. 2022 Mar 4;16(1):37-48.
Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA. 2016 May 24-31;315(20):2190-9.
Snow TAC, Littlewood S, Corredor C, et al. Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis. Blood Purif. 2021;50(4-5):462-472.
Chadban SJ, Ahn C, Axelrod DA, et al. Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation. 2020 Apr;104(4):708-714.
Agarwal KA, Patel H, Agrawal N, et al. Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the United States. Kidney Int Rep. 2021 Jul 14;6(9):2348-2357.
Melvinsdottir I, Foley DP, Hess T, et al. Heart and kidney transplant: should they be combined or subsequent? ESC Heart Fail. 2020 Oct;7(5):2734-2743.
Gallo M, Trivedi JR, Schumer EM, et al. Combined Heart-Kidney Transplant Versus Sequential Kidney Transplant in Heart Transplant Recipients. J Card Fail. 2020 Jul;26(7):574-579.
Bonello L, Delmas C, Schurtz G, et al. Mechanical circulatory support in patients with cardiogenic shock in intensive care units: A position paper of the "Unité de Soins Intensifs de Cardiologie" group of the French Society of Cardiology, endorsed by the "Groupe Athérome et Cardiologie Interventionnelle" of the French Society of Cardiology. Arch Cardiovasc Dis. 2018 Oct;111(10):601-612.
Moeller C, Fleischmann C, Thomas-Rueddel D, et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care. 2016 Oct;35:75-83.
Liu C, Lu G, Wang D, Lei Y, Mao Z, Hu P, Hu J, Liu R, Han D, Zhou F. Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis. Am J Emerg Med. 2019 Nov;37(11):2072-2078.
Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016 Dec;42(12):1922-1934.
Böhm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017 Jun 3;389(10085):2226-2237.
Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013 Apr;165(4):575-582.e3.
Barratt J, Sulowicz W, Schömig M, et al. Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies. Adv Ther. 2021 Oct;38(10):5345-5360.
Chertow GM, Pergola PE, Farag YMK, et al. PRO2TECT Study Group. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 Apr 29;384(17):1589-1600.
Zhao M, Qu H, Wang R, Yu Y, Chang M, Ma S, Zhang H, Wang Y, Zhang Y. Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021 Sep 3;100(35):e26544.
Sinnathamby ES, Banh KT, Barham WT, et al. Hyperkalemia: Pharmacotherapies and Clinical Considerations. Cureus. 2024 Jan 26;16(1):e52994.
Gonseth J, Guallar-Castillón P, Banegas JR, et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J. 2004 Sep;25(18):1570-95.
Junarta J, Fernandez M, Chung I, et al. Role of a cardio-renal multi-disciplinary team meeting in managing cardiovascular risk in patients on kidney transplant waitlists. Clin Transplant. 2020 Nov;34(11):e14061.
Curtis BM, Ravani P, Malberti F, et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant. 2005 Jan;20(1):147-54.
Hotta K, Taniguchi R, Nakayama H, Yamaguchi F, Sato Y. The Effects of an Oral Nutritional Supplement with Whey Peptides and Branched-Chain Amino Acids for Cardiac Rehabilitation of Patients with Chronic Heart Failure. Int Heart J. 2021 Nov 30;62(6):1342-1347. doi: 10.1536/ihj.21-102. Epub 2021 Nov 17. PMID: 34789638.
Chou CL , Chen JS , Kang YN, et al. Association of polyunsaturated fatty acids with improved heart rate variability and cardiovascular events in patients with end-stage renal disease receiving maintenance dialysis: a systematic review and meta-analysis of randomized controlled trials. Food Funct. 2021 Sep 7;12(17):8090-8099.
Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013 Feb;97(2):268-75. doi: 10.3945/ajcn.112.040741.
Zhao JD, Jia JJ, Dong PS, et al. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials. BMJ Open. 2018 Aug 30;8(8):e020545.
Long L, Mordi IR, Bridges C, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev. 2019 Jan 29;1(1):CD003331.
Ng CZ, Tang SC, Chan M, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavioral therapy for hemodialysis patients with depression. J Psychosom Res. 2019 Nov;126:109834.
Ferrell BR, Twaddle ML, Melnick A, et al. National Consensus Project Clinical Practice Guidelines for Quality Palliative Care Guidelines, 4th Edition. J Palliat Med. 2018 Dec;21(12):1684-1689.
Nishikawa Y, Hiroyama N, Fukahori H, et al. Advance care planning for adults with heart failure. Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD013022.
Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730. doi: 10.1155/2013/479730. Epub 2013 Mar 21. PMID: 23573420; PMCID: PMC3618922.
Daniels, L. B., Maisel, A. S., & Januzzi, J. L. (2015). State of the Art: Newer biomarkers in heart failure. European Journal of Heart Failure, 17(6), 559-569. https://doi.org/10.1002/ejhf.273
Eren Z, Ozveren O, Buvukoner E et al. A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences. Cardiorenal Med. 2012 Aug;2(3):168-176. 16.